newsfilter
← Latest News
Business Wire·

Contineum Therapeutics to Present at the Stifel 2026 Healthcare Conference

  • Contineum Therapeutics management will present at the Stifel 2026 Healthcare Conference on Thursday, November 12, 2026, at 8:40 a.m. ET.
  • An audio webcast of the fireside chat will be accessible via the Investors section of Contineum's website, with a replay available.
  • Contineum is a clinical-stage biopharmaceutical company developing oral small molecule therapies for inflammatory & fibrotic diseases.
  • The company's lead candidate PIPE-791 is an LPA1 receptor antagonist in clinical development for idiopathic pulmonary fibrosis & chronic pain.
  • PIPE-307, a selective M1 receptor inhibitor, is in clinical development by Johnson & Johnson for major depressive disorder.